Explore the Agenda

8:00 am Registration & Morning Coffee

8:30 am Chair’s Welcome & Opening Remarks

Former Senior Vice President, People Strategy & Administrative Operations, Senti Biosciences Inc.

Scaling People Strategy to Match Commercial Ambition

8:40 am Panel: The Talent Inflection Point: What HR & TA Leaders Must Get Right During Commercialization & Ownership Transition

Chief People Officer, Cardurion Pharmaceuticals
Vice President, Talent Acquisition, Intellia Therapeutics
Chief Relationship Officer & Platinum Executive Coach, Lead3R

For life sciences organizations, the moments of greatest strategic change, a commercial launch, an IPO, or a move to private ownership, are also the moments of greatest people risk. Culture can fracture, critical talent can walk, and the hiring demands can overwhelm even the best-prepared teams. This panel draws on real experience of navigating these inflection points to surface the people decisions that matter most, the mistakes most commonly made, and the practical approaches that keep organizations on track through their most consequential transitions.

9:20 am Discover: Re-Energizing Engagement by Bringing Performance & Reward Back to Basics in a Modern Biotech

Head of People, Grey Wolf Therapeutics
  • How can biotechs cut through complexity to strengthen engagement, motivation, and trust, especially after years of industry volatility and inconsistent talent practices?
  • Learn how Grey Wolf Therapeutics implemented a back-to-basics, radically transparent approach to objective-setting, performance clarity, and pay communication, anchored on one simple principle: every employee should confidently answer “What do you want me to do?”, “What does good look like?”, and “What will I be rewarded with if I achieve it?”
  • Discover how this restored HR credibility, eliminated ambiguity, reduced pockets of pay disparity, and unlocked significant cultural energy, enabling higher engagement, greater fairness, and a more empowered, high-performing workforce without expensive L&D programs or large HR teams

9:40 am Develop: Simplifying Complexity While Scaling Sustainably

Head of People, Grey Wolf Therapeutics

This interactive Q&A explores how life sciences organizations can scale operations, capability, and workforce complexity without losing clarity, engagement, and organizational discipline no matter what their size. Drawing on the case studies, this session focuses on how to balance growth with simplicity.

10:00 am Action: Building Simplicity & Scalability Into Your Operating Model

Building on the Q&A, this roundtable creates a practical space to reflect on how complexity is showing up in your own organization, and to identify the highest-impact moves to simplify and scale effectively whether you are emerging or established.

Leave with practical actions to reduce complexity, strengthen clarity, and build a more scalable and effective life sciences organization.

10:20 am Networking Break & Refreshments

Track A - Human Resources

Clearing the Path for Faster, Smarter Decisions & Navigating Cultural Complexity

Vice President, Total Rewards, Insulet Corporation

10:50 am Discover: Stopping Organizational Swirl by Clarifying Decision‑Making in R&D

Senior Vice President, Development Operations, Ultragenyx Pharmaceutical Inc.
  • How can life sciences organizations reduce decision‑making friction and role confusion that slows execution across R&D?
  • Learn how Ultragenyx diagnosed ‘organizational swirl’ and introduced the Stop the Swirl initiative and Fix It framework using live forums, real‑time coaching, and embedded decision tools
  • See how this approach drove sustained cross‑level engagement over 18 months, with measurable participation data and strong qualitative feedback, leading to clearer accountability, shared decision language, and improved execution discipline across teams

11:10 am Discover: Sustaining Culture Through Hypergrowth: How Santhera Pharmaceuticals Retained Its Identity While Doubling in Size

Global Head People & Culture, Santhera Pharmaceuticals
  • How can a biotech company safeguard its entrepreneurial spirit during a period of hypergrowth and commercialization?
  • Learn how Santhera embedded cultural ambassadors, prioritized hiring for cultural fit, and elevated employee experience as a strategic driver of scale
  • Even while growing at record pace, Santhera preserved its core identity and strengthened engagement, ensuring culture became a catalyst rather than a casualty of expansion

11:30 am Develop: Scaling with Clarity: Preserving Culture and Accelerating Decisions

Senior Vice President, Development Operations, Ultragenyx Pharmaceutical Inc.
Global Head People & Culture, Santhera Pharmaceuticals

As life sciences organizations grow, maintaining a strong culture while ensuring fast, effective decision-making becomes increasingly challenging. This interactive Q&A explores practical strategies for protecting organizational identity, reducing decision friction, and creating the clarity needed to sustain performance through periods of rapid growth and transformation.

  • Maintaining cultural consistency and employee engagement during rapid expansion
  • Defining clear decision rights and accountability in complex, cross-functional environments
  • Embedding frameworks, tools, and behaviors that reduce organizational friction
  • Building leadership capability, coaching practices, and cultural ambassador networks that reinforce ways of working

11:50 am Action: From Growth to Execution: Building a Culture of Accountability (Roundtable Discussion)

This roundtable invites participants to examine how culture and decision-making intersect to influence organizational performance. Building on the Q&A discussion, attendees will share experiences and practical approaches for sustaining engagement, clarifying accountability, and strengthening execution as organizations evolve and scale.

  • How can organizations preserve their core culture and values during periods of rapid growth?
  • Where do role confusion and decision bottlenecks most commonly emerge, and how can they be addressed?
  • What practices help reinforce accountability, ownership, and effective cross-functional collaboration?
  • How can leaders create shared language, frameworks, and behaviors that support both culture and execution?

Leave with practical frameworks for reducing organizational friction and building the clarity your teams need to execute with greater speed and confidence

Track B - Talent Acquisition
Track C - Learning & Development

12:10 pm Networking Lunch

1:10 pm Speed Learning

Head of Talent Strategy & Enablement, Charles River Laboratories
Global Human Resources Head for R&D & Enabling Functions,, CSL
Head, Global Talent Acquisition, Blueprint Medicines
Vice President, Human Resources, Arcus Biosciences
Vice President, Talent Management, Ardelyx
Senior Vice President, Development Operations, Ultragenyx Pharmaceutical Inc.

End the conference with a high-energy Speed Learning session designed to maximize the value of your time in the room. Through a series of rapid-fire, facilitated discussions, you’ll tackle a curated set of the most pressing challenges facing HR, TA, and L&D leaders today – gaining diverse perspectives, sharing practical solutions, and leaving with a final set of actionable ideas to take back to your organization.

2:10 pm Chair’s Closing Remarks & End of LEAP HR: Life Sciences East 2026